NASDAQ · SIBNHealthcareSurgical Instruments

SI-BONE financials

$19.15+2.08%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
FY20
Dec 31
FY19
Dec 31
FY18
Dec 31
Revenue$200.9M$167.2M$138.9M$106.4M$90.2M$73.4M$67.3M$55.4M
Gross profit$159.9M$132.1M$109.4M$90.7M$79.7M$64.5M$60.5M$50.5M
Gross margin79.6%79.0%78.8%85.2%88.4%87.9%89.9%91.3%
Operating income-$22.3M-$35.2M-$46.9M-$59.6M-$51.7M-$38.6M-$36.0M-$12.0M
Net income-$18.9M-$30.9M-$43.3M-$61.3M-$56.6M-$43.7M-$38.4M-$17.5M
Net margin−9.4%−18.5%−31.2%−57.6%−62.8%−59.5%−57.1%−31.5%
Diluted EPS$-0.44$-0.75$-1.13$-1.79$-1.71$-1.50$-1.55$-2.20
EBITDA-$16.6M-$30.9M-$41.5M-$56.2M-$49.6M-$37.4M-$35.2M-$11.2M
Operating cash flow-$675.0K-$12.4M-$18.7M-$41.7M-$39.5M-$30.7M-$31.6M-$14.5M
Free cash flow-$9.1M-$22.9M-$26.5M-$51.2M-$45.9M-$33.2M-$34.1M-$15.5M
Diluted shares43.0M41.5M38.4M34.2M33.1M29.1M24.7M8.0M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$42.2M$34.9M$33.3M$20.7M$63.4M$53.6M
Short-term investments$105.6M$115.1M$132.7M$76.6M$83.6M$142.9M
Total debt$35.6M$35.5M$36.1M$35.2M$35.0M$39.5M
Total assets$238.6M$230.4M$230.4M$157.6M$190.5M$223.1M
Total liabilities$61.0M$63.5M$61.0M$59.3M$56.1M$53.8M
Shareholders' equity$177.5M$167.0M$169.4M$98.3M$134.4M$169.4M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology